Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation.

MacDonald KP, Palmer JS, Cronau S, Seppanen E, Olver S, Raffelt NC, Kuns R, Pettit AR, Clouston A, Wainwright B, Branstetter D, Smith J, Paxton RJ, Cerretti DP, Bonham L, Hill GR, Hume DA.

Blood. 2010 Nov 11;116(19):3955-63. doi: 10.1182/blood-2010-02-266296. Epub 2010 Aug 3.

2.

Ligand binding induces Cbl-dependent EphB1 receptor degradation through the lysosomal pathway.

Fasen K, Cerretti DP, Huynh-Do U.

Traffic. 2008 Feb;9(2):251-66. Epub 2007 Dec 19.

3.

Caveolin-1 is required for signaling and membrane targeting of EphB1 receptor tyrosine kinase.

Vihanto MM, Vindis C, Djonov V, Cerretti DP, Huynh-Do U.

J Cell Sci. 2006 Jun 1;119(Pt 11):2299-309.

4.

EphB2 regulates axonal growth at the midline in the developing auditory brainstem.

Cramer KS, Cerretti DP, Siddiqui SA.

Dev Biol. 2006 Jul 1;295(1):76-89. Epub 2006 Apr 13.

5.

Tonotopic gradients of Eph family proteins in the chick nucleus laminaris during synaptogenesis.

Person AL, Cerretti DP, Pasquale EB, Rubel EW, Cramer KS.

J Neurobiol. 2004 Jul;60(1):28-39.

6.

EphB1-mediated cell migration requires the phosphorylation of paxillin at Tyr-31/Tyr-118.

Vindis C, Teli T, Cerretti DP, Turner CE, Huynh-Do U.

J Biol Chem. 2004 Jul 2;279(27):27965-70. Epub 2004 Apr 23.

7.

Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors.

Cheng N, Brantley D, Fang WB, Liu H, Fanslow W, Cerretti DP, Bussell KN, Reith A, Jackson D, Chen J.

Neoplasia. 2003 Sep-Oct;5(5):445-56.

8.

Angiopoietin/Tek interactions regulate mmp-9 expression and retinal neovascularization.

Das A, Fanslow W, Cerretti D, Warren E, Talarico N, McGuire P.

Lab Invest. 2003 Nov;83(11):1637-45.

PMID:
14615417
9.

Studies of ligand-induced site-specific phosphorylation of epidermal growth factor receptor.

Guo L, Kozlosky CJ, Ericsson LH, Daniel TO, Cerretti DP, Johnson RS.

J Am Soc Mass Spectrom. 2003 Sep;14(9):1022-31.

10.

EphB1 recruits c-Src and p52Shc to activate MAPK/ERK and promote chemotaxis.

Vindis C, Cerretti DP, Daniel TO, Huynh-Do U.

J Cell Biol. 2003 Aug 18;162(4):661-71.

11.

Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.

Cheng N, Brantley DM, Liu H, Lin Q, Enriquez M, Gale N, Yancopoulos G, Cerretti DP, Daniel TO, Chen J.

Mol Cancer Res. 2002 Nov;1(1):2-11.

12.

Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo.

Brantley DM, Cheng N, Thompson EJ, Lin Q, Brekken RA, Thorpe PE, Muraoka RS, Cerretti DP, Pozzi A, Jackson D, Lin C, Chen J.

Oncogene. 2002 Oct 10;21(46):7011-26.

13.

Expression of EphB receptors and EphrinB ligands in the developing chick auditory brainstem.

Cramer KS, Karam SD, Bothwell M, Cerretti DP, Pasquale EB, Rubel EW.

J Comp Neurol. 2002 Oct 7;452(1):51-64.

PMID:
12205709
14.

Ephrin-B1 transduces signals to activate integrin-mediated migration, attachment and angiogenesis.

Huynh-Do U, Vindis C, Liu H, Cerretti DP, McGrew JT, Enriquez M, Chen J, Daniel TO.

J Cell Sci. 2002 Aug 1;115(Pt 15):3073-81.

15.

Ephrins stimulate neurite outgrowth during early cortical neurogenesis.

Zhou X, Suh J, Cerretti DP, Zhou R, DiCicco-Bloom E.

J Neurosci Res. 2001 Dec 15;66(6):1054-63.

PMID:
11746437
16.

Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme.

Reddy P, Slack JL, Davis R, Cerretti DP, Kozlosky CJ, Blanton RA, Shows D, Peschon JJ, Black RA.

J Biol Chem. 2000 May 12;275(19):14608-14.

17.

Spinal motor axons and neural crest cells use different molecular guides for segmental migration through the rostral half-somite.

Koblar SA, Krull CE, Pasquale EB, McLennan R, Peale FD, Cerretti DP, Bothwell M.

J Neurobiol. 2000 Mar;42(4):437-47.

PMID:
10699981
18.

Selective inhibition of spinal cord neurite outgrowth and cell survival by the Eph family ligand ephrin-A5.

Yue Y, Su J, Cerretti DP, Fox GM, Jing S, Zhou R.

J Neurosci. 1999 Nov 15;19(22):10026-35.

19.

The identification of seven metalloproteinase-disintegrin (ADAM) genes from genomic libraries.

Poindexter K, Nelson N, DuBose RF, Black RA, Cerretti DP.

Gene. 1999 Sep 3;237(1):61-70.

PMID:
10524237
20.

Isolation of two novel metalloproteinase-disintegrin (ADAM) cDNAs that show testis-specific gene expression.

Cerretti DP, DuBose RF, Black RA, Nelson N.

Biochem Biophys Res Commun. 1999 Oct 5;263(3):810-5.

PMID:
10512762
21.

Characterization of the cDNA and gene for mouse tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and its location to mouse chromosome 12 and human chromosome 2p25.

Cerretti DP, Poindexter K, Castner BJ, Means G, Copeland NG, Gilbert DJ, Jenkins NA, Black RA, Nelson N.

Cytokine. 1999 Aug;11(8):541-51.

PMID:
10433800
22.

Surface densities of ephrin-B1 determine EphB1-coupled activation of cell attachment through alphavbeta3 and alpha5beta1 integrins.

Huynh-Do U, Stein E, Lane AA, Liu H, Cerretti DP, Daniel TO.

EMBO J. 1999 Apr 15;18(8):2165-73.

23.

Ephrin-dependent growth and pruning of hippocampal axons.

Gao PP, Yue Y, Cerretti DP, Dreyfus C, Zhou R.

Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):4073-7.

24.

Characterization of the tumour necrosis factor alpha-converting enzyme, TACE/ADAM17.

Cerretti DP.

Biochem Soc Trans. 1999 Feb;27(2):219-23. Review. No abstract available.

PMID:
10093737
25.

Specification of distinct dopaminergic neural pathways: roles of the Eph family receptor EphB1 and ligand ephrin-B2.

Yue Y, Widmer DA, Halladay AK, Cerretti DP, Wagner GC, Dreyer JL, Zhou R.

J Neurosci. 1999 Mar 15;19(6):2090-101.

26.

An essential role for ectodomain shedding in mammalian development.

Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC, Russell WE, Castner BJ, Johnson RS, Fitzner JN, Boyce RW, Nelson N, Kozlosky CJ, Wolfson MF, Rauch CT, Cerretti DP, Paxton RJ, March CJ, Black RA.

Science. 1998 Nov 13;282(5392):1281-4.

27.

Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor.

Buxbaum JD, Liu KN, Luo Y, Slack JL, Stocking KL, Peschon JJ, Johnson RS, Castner BJ, Cerretti DP, Black RA.

J Biol Chem. 1998 Oct 23;273(43):27765-7.

28.

Expression and purification of correctly processed, active human TACE catalytic domain in Saccharomyces cerevisiae.

Clarke HR, Wolfson MF, Rauch CT, Castner BJ, Huang CP, Gerhart MJ, Johnson RS, Cerretti DP, Paxton RJ, Price VL, Black RA.

Protein Expr Purif. 1998 Jun;13(1):104-10.

PMID:
9631522
29.

Regulation of thalamic neurite outgrowth by the Eph ligand ephrin-A5: implications in the development of thalamocortical projections.

Gao PP, Yue Y, Zhang JH, Cerretti DP, Levitt P, Zhou R.

Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5329-34.

30.

Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme.

Maskos K, Fernandez-Catalan C, Huber R, Bourenkov GP, Bartunik H, Ellestad GA, Reddy P, Wolfson MF, Rauch CT, Castner BJ, Davis R, Clarke HR, Petersen M, Fitzner JN, Cerretti DP, March CJ, Paxton RJ, Black RA, Bode W.

Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3408-12.

31.

Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses.

Stein E, Lane AA, Cerretti DP, Schoecklmann HO, Schroff AD, Van Etten RL, Daniel TO.

Genes Dev. 1998 Mar 1;12(5):667-78.

32.

CD30 and its ligand: possible role in regulation of teratoma stem cells.

Pera MF, Bennett W, Cerretti DP.

APMIS. 1998 Jan;106(1):169-72; discussion 173. Review.

PMID:
9524575
34.

Nck recruitment to Eph receptor, EphB1/ELK, couples ligand activation to c-Jun kinase.

Stein E, Huynh-Do U, Lane AA, Cerretti DP, Daniel TO.

J Biol Chem. 1998 Jan 16;273(3):1303-8.

35.

LERK-7: a ligand of the Eph-related kinases is developmentally regulated in the brain.

Kozlosky CJ, VandenBos T, Park L, Cerretti DP, Carpenter MK.

Cytokine. 1997 Aug;9(8):540-9.

PMID:
9245480
36.

Ligand for EPH-related kinase (LERK) 7 is the preferred high affinity ligand for the HEK receptor.

Lackmann M, Mann RJ, Kravets L, Smith FM, Bucci TA, Maxwell KF, Howlett GJ, Olsson JE, Vanden Bos T, Cerretti DP, Boyd AW.

J Biol Chem. 1997 Jun 27;272(26):16521-30.

37.

Expression of CD30 and CD30 ligand in cultured cell lines from human germ-cell tumors.

Pera MF, Bennett W, Cerretti DP.

Lab Invest. 1997 Apr;76(4):497-504.

PMID:
9111512
38.

A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation.

Delsol G, Lamant L, Mariamé B, Pulford K, Dastugue N, Brousset P, Rigal-Huguet F, al Saati T, Cerretti DP, Morris SW, Mason DY.

Blood. 1997 Mar 1;89(5):1483-90.

39.

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells.

Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP.

Nature. 1997 Feb 20;385(6618):729-33.

PMID:
9034190
40.

ELK and LERK-2 in developing kidney and microvascular endothelial assembly.

Daniel TO, Stein E, Cerretti DP, St John PL, Robert B, Abrahamson DR.

Kidney Int Suppl. 1996 Dec;57:S73-81.

PMID:
8941926
41.
42.

Cell-cell adhesion mediated by binding of membrane-anchored ligand LERK-2 to the EPH-related receptor human embryonal kinase 2 promotes tyrosine kinase activity.

Böhme B, VandenBos T, Cerretti DP, Park LS, Holtrich U, Rübsamen-Waigmann H, Strebhardt K.

J Biol Chem. 1996 Oct 4;271(40):24747-52.

43.
44.

The gene encoding LERK-7 (EPLG7, Epl7), a ligand for the Eph-related receptor tyrosine kinases, maps to human chromosome 5 at band q21 and to mouse chromosome 17.

Cerretti DP, Copeland NG, Gilbert DJ, Jenkins NA, Kuefer MU, Valentine V, Shapiro DN, Cui X, Morris SW.

Genomics. 1996 Jul 15;35(2):376-9.

PMID:
8661153
45.

The genes encoding the eph-related receptor tyrosine kinase ligands LERK-1 (EPLG1, Epl1), LERK-3 (EPLG3, Epl3), and LERK-4 (EPLG4, Epl4) are clustered on human chromosome 1 and mouse chromosome 3.

Cerretti DP, Lyman SD, Kozlosky CJ, Copeland NG, Gilbert DJ, Jenkins NA, Valentine V, Kirstein MN, Shapiro DN, Morris SW.

Genomics. 1996 Apr 15;33(2):277-82.

PMID:
8660976
46.

Isolation of LERK-5: a ligand of the eph-related receptor tyrosine kinases.

Cerretti DP, Vanden Bos T, Nelson N, Kozlosky CJ, Reddy P, Maraskovsky E, Park LS, Lyman SD, Copeland NG, Gilbert DJ, et al.

Mol Immunol. 1995 Nov;32(16):1197-205.

PMID:
8559144
47.

Ligands for EPH-related tyrosine kinase receptors are developmentally regulated in the CNS.

Carpenter MK, Shilling H, VandenBos T, Beckmann MP, Cerretti DP, Kott JN, Westrum LE, Davison BL, Fletcher FA.

J Neurosci Res. 1995 Oct 1;42(2):199-206.

PMID:
8568920
48.

Ligands for the receptor tyrosine kinases hek and elk: isolation of cDNAs encoding a family of proteins.

Kozlosky CJ, Maraskovsky E, McGrew JT, VandenBos T, Teepe M, Lyman SD, Srinivasan S, Fletcher FA, Gayle RB 3rd, Cerretti DP, et al.

Oncogene. 1995 Jan 19;10(2):299-306.

PMID:
7838529
49.

Genetic and physical mapping of 2q35 in the region of the NRAMP and IL8R genes: identification of a polymorphic repeat in exon 2 of NRAMP.

White JK, Shaw MA, Barton CH, Cerretti DP, Williams H, Mock BA, Carter NP, Peacock CS, Blackwell JM.

Genomics. 1994 Nov 15;24(2):295-302.

PMID:
7698752
50.

Human macrophage colony-stimulating factor is expressed at and shed from the cell surface.

Tuck DP, Cerretti DP, Hand A, Guha A, Sorba S, Dainiak N.

Blood. 1994 Oct 1;84(7):2182-8.

Supplemental Content

Loading ...
Support Center